Debevoise & Plimpton advised Valenz Health on the transaction, and Goodwin Procter advised Healthcare Bluebook. Valenz Health announced it has acquired Healthcare Bluebook. Stifel and Raymond...
Valenz Health’s Acquisition of Healthcare Bluebook
Addus HomeCare’s $350 Million Acquisition of Addus HomeCare
Bass Berry & Sims advised Addus on the transaction, while Debevoise & Plimpton and Ropes & Gray advised Gentiva. Addus HomeCare Corporation (Nasdaq: ADUS), a provider...
Clayton, Dubilier & Rice’s Partnership with Elevance Health
Debevoise & Plimpton is advising Clayton, Dubilier & Rice on the transaction, and White & Case is advising Elevance Health, Inc. Clayton, Dubilier & Rice (CD&R)...
Kelso & Company’s Investment in Valenz
Debevoise & Plimpton LLP has advised Kelso & Company in the transaction. Kelso & Company executed its investment in Valenz® Health (“Valenz”). Kelso & Company is one...
Pernod Ricard’s Acquisition of a Majority Stake in Skrewball
Debevoise & Plimpton advised Pernod Ricard, while Latham & Watkins advised Skrewball and the founders in the transaction. Pernod Ricard announced its acquisition of a majority stake...
Gentiva’s Acquisition of Heartland Hospice and Home Care from ProMedica
Debevoise & Plimpton LLP and Ropes & Gray LLP advised Gentiva, while BakerHostetler advised ProMedica. Gentiva, a dedicated hospice, palliative, and personal care company driving improved...